Summary Two radiorespirometric assays, the BACTEC 460 and Buddemeyer type 14C0 2 detection systems, were evaluated in a double-blind manner for their ability to discriminate between authentic antileprosy agents and inactive compounds. Freshly harvested, nude-mouse derived My cobacterium leprae were incubated in axenic media in the presence of coded test solutions prepared in a remote laboratory. Activity was assessed by comparing the rate of 14C0 2 evolution from [1-14C]palmitic acid to controls. Breaking the code revealed that both systems demonstrated a dose response to ethionamide, pefloxacin and rifampicin as well as sensitivity to dapsone. Most of the water, ethanol, sucrose, dabsyl chloride and riboflavin negative-control samples failed to effect a significant reduction in radiorespirometric activity. This study confirms the ability of the radiorespirometric assays to fu nction as a primary drug screening system in leprosy.
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Historically, the screening of compounds for activity against My cobacterium /eprae has had to utilize the mouse fo otpad modell-3 because of the failure to cultivate the leprosy bacillus in vitro. The high cost, the length of time (6-12 months per experiment), the requirement for gram quantities of drug and the dependence on non-human pharmacoki netics4 have all motivated investigators to develop rapid in vitro systems which measure bacterial metabolism (following exposure to antimicrobial agents) as an index of viability. [5] [6] [7] The ability of M. /eprae to oxidize rapidly palmitic acid to carbon dioxide8-10 has been exploited by when screening for new antileprosy drugs, using two related assay systems: a Buddemeyer-type, liquid scintillation based, two-compartment system 10 and an adaptation of the commercial BACTEC 460 system. I I These systems are very similar in that they both quantitate the rate of 14C0 2 evolution from 14C-labelled substrates. Both are 'automated' systems which do not require host cells, subsampling, extraction, filtration or other processing fo llowing the incubation of bacilli with drugs.
The present WHO-sponsored, double-blind study was undertaken to evaluate objectively the utility of these systems in screening for anti leprosy drugs. Coded samples of compounds with known antileprosy activity, and control samples with no activity, were prepared in the London laboratory and sent to the Carville laboratory where they were tested in the two in vitro assays. In this way we were able to assess the reliability and reproducibility of the assays in screening for antileprosy activity.
Methods
The drug solutions were composed of stock solutions of rifampicin (RMP; 2·S mg/ml in ethanol), ethionamide (ETH), dapsone (DDS; S mg/ml in ethanol), and pefloxacin (PEF; S mg/ml in water) and were prepared at NIMR (London). Triplicate 0· 1 ml aliquots of these stock solutions, together with 2·S-fold, S-fold and 10-fold dilutions were provided for a subsequent I OO-fold dilution in the test media following filter sterilization. Negative control solutions consisted of distilled water, absolute ethanol, I % sucrose, riboflavin (O·S mg/ml), and dabsyl chloride (0· 1 mg/ml). These last two acted as colour controls for ethionamide and rifampicin, respectively. The 70 test samples were coded, randomized, stored at -20DC and shipped on dry ice to the Carville laboratory where they were held at -20DC until used.
M. LEPRAE INOCULUM
M. teprae was harvested from the fo otpads ofathymic nu/nu mice when the fo otpads had reached a bacillary load of approximately 1010 AFB. Footpads were surface decontami nated with iodine and ethanol, minced and homogenized in 7H I2 medium (Middlebrook 7H9 broth, 0· 1 % casitone (Difco), 1% w/v albumin and S Ilg/ml catalase). The bulk of tissue debris was removed by slow-speed centrifugation (l08 x g, S min, IODC) and the bacilli pelleted (27 10 x g, 4S min, IODC) and resuspended in 7Hl2 medium to approxima tely 109 /m\. Cell counts were determined by the method of Shepard & McRae. 18 The suspensions were treated with so Ilg/ml ampicillin and 2· S Ilg/ml amphotericin B for 4-S h to eliminate contaminants. These agents have repeatedly been shown to be inactive against M. teprae.10•19 Aliquots of the bacillary suspension were inoculated into Middlebrook 7H II and Lowenstein-Jensen slants, tryptic soy and thioglycollate broths and blood agar to check for contaminants.
BACTEC
The M. teprae suspension was diluted to 108/ml in 7H 12 medium and 0· 1 ml aliquots (107 AFB) delivered via tuberculin syringe to BACTEC 12B media (4 ml in 20 ml serum vials) supplemented with so Ilg/ml ampicillin and 2·S llg/ml amphotericin B. The controls were 16 cultures that had received 0· 1 ml 7H9 broth. Other cultures received 0· 1 ml of coded test solutions in quadruplicate. All vials were flushed with 2·S% oxygen, 10% carbon dioxide, balance nitrogen using the BACTEC 460 instrument and were then incubated at 33DC. The growth index (GI, 14C0 2 evolution) was determined at weekly intervals for 3 weeks in the BACTEC 460 by flushing with the above gas mixture. Readings from week 2 were used in evaluating activity.
BUDDEMEYER
The M. leprae suspension was diluted to 106/ml in 7H 12 medium and I ml aliquots (106 AFB) dispensed to 6 ml screw-capped vials (Wheaton, Millville, NJ, USA). The controls were 16 cultures who received 10 fil 7H9 broth. Other cultures received 10 fil of coded test solutions in quadruplicate. Vials, with loose caps, were then incubated for 2 weeks at 33°C under an atmosphere of 2·5% oxygen, 10% carbon dioxide in an incubator with automatic oxygen and carbon dioxide control capability, and I microCurie of [1_14C] palmitic acid (58 mCi/mmole; New England Nuclear, Boston, MA, USA) was added to each vial in a volume of 10 fil ethanol. The glass vials, with loose caps, were then placed within wide-mouth scintillation vials (Poly-Q; Beckman, Brea, CA) containing a 2 x 4 cm strip of What man No. 42 filter paper which had previously been dipped into a mixture of 20 ml Liquifluor concentrate (New England Nuclear), 15 g PPO, 5 ml Triton-X 100 and 5 ml 2N NaOH (in MeOH). The entire assembly was incubated at 33°C and 14C0 2 evolution determined at daily intervals for I week by placing the double vial assemblies in a liquid scintillation counter. Cumulative counts per minute from the day 7 reading were used in evaluating activity.
STATISTICAL EVALUATION
Statistical significance was determined by the Student's (-test.
Results

BACTEC
Using a p value of 0·05 as a cut-off for active substances, there were 6 fa lse positives out of 22 non-antileprosy substances (Table I) 
BUDDE MEYER
Only 1 of the 22 non-antileprosy substances appeared active, possibly due to the large SD obtained with this sample (A20) ( Table 2) . Results with DDS were variable, although 2 of 3 samples were positive at 0·5, 2·0 and 5·0 fig/m\. Both ETH and PEF gave inconclusive results at 0· 1 fig/ml and significant dose-responsive activity at the 3 higher concentrations.
All concentrations of RMP again demonstrated highly significant, dose-dependent activity. This double-blind, 2-laboratory evaluation of these in vitro radiorespirometric systems confirms previous reports on the ability of these assays to detect activity of established antileprosy drugs at concentrations below peak obtainable plasma levels.1o-1 2 All of the known antileprosy compounds were fo und to be active at the concentrations which they would be predicted to be active and there was good concordance between replicate samples. Results from earlier studies and this report suggest a correlation between degree of drug activity in the mouse fo otpad 19-2 4 and radiorespirometric systems.II,1 2 ,14,16 In general, highly active, potent drugs such as RMP produced lower levels of 14C0 2 than bacteriostatic agents such as DDS. Since all concentrations of RMP were active in both Buddemeyer and the BACTEC systems, we were unable to determine an MIC. The MIC of ethionamide, as measured by the in vitro systems, appeared to be between 0· 1 and O· 5 ,ug/ml (compared to 0·05 ,ug/ml as estimated by the mouse fo otpad system). All concentrations of DDS were active in the BACTEC system, whereas in the Buddemeyer system occasional samples at all concentrations were fo und to be inactive, making it difficult to compare the MIC in vitro with that estimated using the mouse fo otpad technique (approximately 0.003 ,ug/ml). Pefloxacin appears to have an MIC of approximately O· 5 ,ug/ml in vitro. Up to now the radiorespirometric systems evaluated in this report have been used to screen 6 macrolides,1 4 17 clofazimine derivatives,15,17 20 fiuoroquinolones,1 6 1 tetracy cline, II 5 aminoglycosides, 3 rifamycins and 2 lincosamides 1 2 for activity against M. leprae. Thus, 2 agents, clarithromycin 14 and sparfioxacin, 1 6 were first recognized as being the most active clinically relevant agents in their respective classes and are currently in clinical trials in leprosy. Another potential anti leprotic identified by radiorespirometry is fu sidic acid,13 an established antibiotic which has poor pharmacokinetics in mice (in contrast to humans) and is inactive against M. leprae in the mouse footpad model (Colston, unpublished results).
There was fairly good agreement (79%) between the BACTEC and Buddemeyer systems, especially considering that the two assays were evaluated in separate experiments at different times using different nude mouse-derived inocula. The BACTEC system requires approximately 10 times more bacilli than the Buddemeyer-type system to obtain usable readings. This relatively lower sensitivity also results in smaller differences observed between control and drug-treated samples than that observed in the Budde meyer system. The BACTEC system, however, appears to be more sensitive to weakly active agents such as DDS and results in lower variance among replicate samples. This may be due to the ability to produce efficiently and maintain the desired (microaerophilic) environment using the BACTEC 460 instrument, which appears optimal for maintenance of M. lep rae viability in vitro. 25 With either test (consisting of approximately 300 vials-70 samples in quadruplicate plus 4 heat-killed and 16 drug-free controls), the numbers evaluated in the present study can be read within a normal 8 hour working day.
Conclusion
Radiorespirometry, using either the BACTEC 460 or Buddemeyer 14C0 2 detection systems, is capable of differentiating between antileprosy agents and inactive substances fo llowing a 2-week incubation of freshly harvested, viable leprosy bacilli under appropriate incubation conditions.
